Journa Health

Let's Connect at Future Food-Tech 2025 this week in San Francisco! The Journa team is eager to link up and learn with fellow attendees passionate about advancing food technology and health. There are a couple of ways to connect: ?? Stop by the Puratos Innovation Challenge on March 13 to see Solarea Bio present along with two other finalists. The winner will be named later that day. ?? CEO Gerardo V. Toledo will present on "Mapping the Microbiome to Unlock Health Benefits Across Life Stages" with Biohm Technologies CEO Sam Schatz and Nimble Science CEO Sabina Bruehlmann on March 14. We hope to see you at both sessions to discover how research and innovations are shaping the future of health through the gut microbiome, including Journa’s Bondia?, a new rigorously tested synbiotic medical food for patients at risk of bone loss. #FutureFoodTech #Networking #SolareaBio #HealthThroughMicrobiome

Headed to Future Food-Tech? Join us for an insightful session! On Friday, March 14, our CEO and Co-Founder Gerardo V. Toledo will present a case study titled "Mapping the Microbiome to Unlock Health Benefits Across Life Stages" with Biohm Technologies CEO Sam Schatz and Nimble Science CEO Sabina Bruehlmann. This session will delve into: ?? Identifying gaps in gut microbiome mapping and its translation to human health solutions. ?? Research needed to understand the microbiome's impact on need states such as cognition and immunity. ?? Leveraging innovations like biosensors and AI for data-driven insights. ?? Latest developments in prebiotics, probiotics, and postbiotics for specific health solutions. Don't miss this opportunity to gain valuable insights into the future of microbiome research and its applications in health. #Microbiome #HealthInnovation #FutureFoodTech #SolareaBio

We are thrilled to announce our participation in the Future Food-Tech summit in San Francisco on March 13-14, 2025. The event brings together global leaders who are committed to a healthy and sustainable future through food. Two highlights: ?? We are finalists in the Puratos Innovation Challenge and will present with the other finalists on March 13. The winner will be named later that day at the summit. ?? CEO Gerardo V. Toledo will present with Biohm Technologies CEO Sam Schatz and Nimble Science CEO Sabina Bruehlmann on, “Mapping the Microbiome to Unlock Health Benefits Across Life Stages” on Friday, March 14 at 11:55 a.m. Learn more in our press release: https://lnkd.in/exxByw6S We look forward to engaging with fellow innovators and exploring the latest advancements in food technology, including our first product, Bondia? (SBD111), a synbiotic medical food to aid in the dietary management of osteopenia and bone loss associated with menopause, weight, and age. #FutureFoodTech #JournaHealth #SolareaBio #FoodInnovation

Thanks to Femtech Insider for their coverage of Journa Health’s launch of Solarea Bio-developed Bondia?, a medical food to aid in the dietary management of bone loss associated with osteopenia, menopause, weight, and age. ? "Solutions for the age-related inflammatory condition osteopenia are a significant unmet need, as consumers lack safe and effective products to manage postmenopausal bone loss," said CEO Gerardo V. Toledo. ? Read the story to see how our AI-driven platform enables development of Bondia? and other medical foods: https://lnkd.in/ekngf5er #MedicalFood #BoneLoss #Osteopenia #Menopause

That’s a wrap on #IHS2025! ?? Over the past three days, we had insightful conversations about the #gut-bone connection, the expanding role of the #microbiome in whole-body health, and how #MedicalFoods like Bondia? are changing how clinicians support bone health and inflammation-driven conditions. Thank you to everyone who stopped by Booth 1211 to learn more about how Journa Health is developing a new era of accessible aging #health innovations! If we didn’t get a chance to connect, reach out—we’d love to continue the conversation>> www.journahealth.com

For years, integrative medicine has recognized the gut’s central role in whole-body #health. Now, cutting-edge research is validating these insights, paving the way for microbiome-based solutions to better support patients. At Journa Health, we’re at the forefront of this shift - developing clinically validated medical foods like Bondia?, a #synbiotic medical food that aids in the dietary management of bone loss associated with #osteopenia, #menopause, weight, and age. ?? We’re at the Integrative Healthcare Symposium 2025 in NYC this week to explore how microbiome-based innovations are reshaping integrative healthcare. Stop by Booth 1211 to learn more! #IHS2025 #MedicalFood #guthealth

A growing body of research reinforces the gut’s role in systemic #health - from immune function to inflammatory balance and bone health. At Journa Health, we’re leading the way in microbiome-based #MedicalFoods, bringing clinically validated solutions like Bondia? to the forefront of integrative patient care. ?? Bondia? (SBD111) is a first-of-its-kind #synbiotic designed to aid in the dietary management of bone loss by enhancing gut barrier function and modulating osteoclast activity to reduce systemic inflammation. Next week, we’ll be at Integrative Healthcare Symposium 2025 in NYC (Booth 1211) to share the latest advancements in microbiome-targeted solutions and detail the #gut-bone axis. ?? If you’re attending IHS 2025, stop by to explore how Bondia? can enhance patient outcomes. #IHS2025 #BoneHealth

We’re excited to share that Journa Health will be exhibiting at the Integrative Healthcare Symposium 2025 in New York City from February 20-22! ?? As healthcare continues to shift toward personalized, integrative solutions, we remain committed to pioneering #microbiome-based innovations that support whole-body health, like Bondia?, a new #synbiotic medical food that aids in the dietary management of bone loss associated with osteopenia, menopause, weight, and age. ?? Visit us at Booth 1211 to explore the clinical applications of Bondia? and learn how Journa is redefining the role of the gut microbiome in patient care. #IHS2025

Recent research has highlighted the gut’s contributions to overall health as well as an opportunity for healthcare providers to prioritize the gut #microbiome for improving patient outcomes. Recently, our Co-Founder and COO Eric Schott, PhD, joined Dr. Jeff Bland, PhD, for a Personalized Lifestyle Medicine Institute webinar, Enhancing Bone Health: Exploring the Role of Synbiotic Therapy, with Journa advisor Dr. Susan Bukata, MD, Chair, Department of Orthopedic Surgery, UC San Diego, to explore the gut-bone axis. ? If you didn’t get a chance to attend, check out Eric’s key takeaways from the in-depth conversations. Among the topics they reviewed were: managing #BoneHealth in clinical settings; how enhancing the #gut barrier function can help to reduce systemic inflammation; and how Bondia?, a new #synbiotic medical food, can target #osteoclast activity to improve outcomes for patients at risk of bone loss. ?? Click here to read his article:?https://lnkd.in/eFqGnN4V

We are thrilled to share that Solarea Bio, which powers our laboratories and clinical discoveries at Journa, has been selected as a finalist for the Puratos Innovation Challenge at the upcoming Future Food-Tech Summit in San Francisco. On March 13, 2025, our CEO and Co-founder Gerardo V. Toledo will take the stage to showcase how Solarea Bio is unlocking the power of the edible plant microbiota to provide natural solutions for patients suffering from inflammatory processes. The Puratos Innovation Challenge features innovative solutions that can modulate the gut microbiome to improve physical health or mental wellbeing. At Journa, we are dedicated to developing natural, microbe-based solutions to address underserved inflammatory conditions, like osteopenia and bone loss, by isolating beneficial organisms from plants. ?? We are honored to be among three finalists presenting our solutions to Puratos and the Future Food-Tech audience. https://lnkd.in/eDEmpajF #FutureFoodTech #PuratosInnovationChallenge #GutHealth #Microbiome #SolareaBio